Background: Hawai’i has above average rates of melanoma, with head and neck melanoma (HNM) considered the most severe. Analysis of discharge records can reveal disease patterns, demographic and geographic disparities. Objective This study describes community and individual factors associated with Hawai’i’s melanoma inpatients between 2016-2023.Methods: Patients diagnosed with melanoma were identified from inpatient discharge records filed between 2016-2023. Multivariable logistic regression identified factors associated with HNM. Zero-truncated negative binomial regression examined factors associated with length of stay (LOS).Results: Of 409 inpatients with melanoma, 67 had it as a principal diagnosis. HNM was less likely to be a secondary diagnosis. Odds of having HNM were highest among males, age >80, or Maui residents. Among patients with principal diagnoses, non-White patients (including Native Hawaiian and Pacific Islanders (NH-PI)) were more likely to have longer LOS than White patients, as did those with more secondary diagnoses Limitations Our dataset only comprised hospitalized melanoma patients, so prevalence cannot be inferred. Additionally, hospital data from self-governed organizations was not accessible for analysis.Conclusion: HNM in Hawai’i was associated with male sex, age > 65, or Maui residence. Non-white patients, particularly NH-PI, and those having a greater number of secondary diagnoses had longer LOS.